Opportunity to participate in the external consultation process of the National Pathology Handbook – New guidelines available


National Laboratory Handbook latest draft guidelines now available for review

The National Clinical Programme for Pathology continues to develop a National Pathology Handbook for Ireland, which will provide a set of national guidelines and order sets for common clinical diagnostic problems, particularly those associated with high volumes or potential over-usage of investigations.

Volume 2. of the National Laboratory Handbook was published in 2018.

The Handbook continues to be developed in stages, with a bundle of new guidelines and reports included in each volume. 

We are now in the process of external consultation for the draft guidelines listed on this webpage and would value your review and feedback.

Feedback to be submitted by 14 December 2018

Your feedback should be entered onto the Word document linked below and emailed to Joan McCormack, Programme Manager at joanmccormack@rcpi.ie

The closing date for feedback is Friday 14 December 2018.

Scope of the Public Hospital Medical Testing Laboratory Network

The purpose of this document is to establish that: laboratories are not obliged to perform all tests requested; That the role of the pathologist is central, both at policy and individual patient level; Policy decisions should be documented; Where a test on an individual patient is not performed, the test request should be recorded and the reason for not performing the test reported to the clinician

Laboratory Testing for Natriuretic Peptides (NP) - BNP / NT- proBNP

This guidance is intended to guide clinicians and clinical laboratories on the appropriate use, result interpretation, performance (diagnostic + analytical) and limitations of testing involving Natriuretic Peptides (NP), BNP or NT-proBNP, in adult patients.

Laboratory Testing for Alpha-1 Antitrypsin Deficiency (AATD) (Version 3.0)

The aim of this guideline is to provide clear guidelines and indications for testing for alpha-1 antitrypsin deficiency that can be used by clinicians and clinical laboratories, including circumstances where testing is not required. These guidelines apply to adult, non-pregnant patients and paediatric patients with cryptogenic liver disease where alpha-1 antitrypsin deficiency is suspected.

Contact us

Joan McCormack

Programme Manager, National Clinical Programmes

Tel: +353 863 9621

Joan McCormack is the Programme Manager for the National Clinical Programme for:

  • Stroke
  • Pathology